Psilocybin’s acute and persistent brain effects: a precision imaging drug trial
Abstract Psilocybin (PSIL) is a psychedelic drug and a promising experimental therapeutic for many psychiatric conditions. Precision functional mapping (PFM) combines densely repeated resting state fMRI sampling and individual-specific network mapping to improve signal-to-noise ratio (SNR) and effec...
Saved in:
| Main Authors: | Subha Subramanian, Travis Rick Reneau, Demetrius Perry, Ravi Chacko, Timothy O. Laumann, Karin Flavin, Christine Horan, Julie Schweiger, Nicholas Metcalf, Eric J. Lenze, Abraham Z. Snyder, Nico U. F. Dosenbach, Ginger Nicol, Joshua S. Siegel |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-06-01
|
| Series: | Scientific Data |
| Online Access: | https://doi.org/10.1038/s41597-025-05189-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correction: Psilocybin’s acute and persistent brain effects: a precision imaging drug trials
by: Subha Subramanian, et al.
Published: (2025-06-01) -
Protocol for a pilot clinical trial of the senolytic drug combination Dasatinib Plus Quercetin to mitigate age-related health and cognitive decline in mental disorders [version 2; peer review: 1 approved, 2 approved with reservations]
by: Eric J Lenze, et al.
Published: (2025-03-01) -
Structural basis for psilocybin biosynthesis
by: Chunyan Meng, et al.
Published: (2025-03-01) -
Pharmacokinetics of Psilocybin: A Systematic Review
by: Shakila Meshkat, et al.
Published: (2025-03-01) -
Is there mush-room to improve the environmental sustainability of psilocybin production?
by: Luke Lanham, et al.
Published: (2025-08-01)